
The concerns were "about study design rather than safety or efficacy itself."
Maybe I'm just jaded, but it reminds me of other examples where drugs focusing on women's health (like birth control) were rejected/delayed, while drugs focusing on men (like Viagra) were quickly OK'd despite higher risk factors.
u/CattyWombats — 13 days ago